Tiziana director granted 15,000 shares of stock

Tiziana Life Sciences Ltd reported that major shareholder and director Gabriele M. Cerrone indirectly acquired 15,000 shares of common stock as a grant or award.

Rhea-AI Filing Summary

Tiziana Life Sciences Ltd reported that major shareholder and director Gabriele M. Cerrone indirectly acquired 15,000 shares of common stock as a grant or award. The shares were credited on June 12, 2026 at $1.11 per share via Panetta Partners Limited, bringing his reported indirect holdings to 44,772,230 shares of common stock.

Insider Trade Summary

Grant/Award: 15,000 shares

Grant/Award 1 txn

Insider CERRONE GABRIELE M

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	COMMON STOCK	15,000	$1.11	$17K

Holdings After Transaction: COMMON STOCK — 44,772,230 shares (Indirect, Via Panetta Partners Limited)

Key Figures

Shares granted: 15,000 shares Grant price: $1.11 per share Indirect holdings after transaction: 44,772,230 shares

3 metrics

Shares granted 15,000 shares Grant/award acquisition on June 12, 2026

Grant price $1.11 per share Price per share for 15,000-share award

Indirect holdings after transaction 44,772,230 shares Total common shares reported following the grant

Key Terms

Form 4, grant/award acquisition, indirect ownership, common stock

4 terms

Form 4 regulatory

"reported on this Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

grant/award acquisition financial

"described as a grant, award, or other acquisition"

indirect ownership financial

"the shares are reported as held indirectly"

common stock financial

"acquired 15,000 shares of common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Tiziana Life Sciences (TLSA) report on this Form 4?

Tiziana Life Sciences reported an insider grant of 15,000 common shares. Director and ten percent owner Gabriele M. Cerrone received the shares as a grant or award, recorded at $1.11 per share on June 12, 2026, via Panetta Partners Limited.

Who is the insider involved in the latest Tiziana Life Sciences (TLSA) Form 4?

The insider is Gabriele M. Cerrone, a director and ten percent owner of Tiziana Life Sciences. He reported an indirect acquisition of 15,000 common shares through Panetta Partners Limited as a grant or award transaction dated June 12, 2026.

How many Tiziana Life Sciences (TLSA) shares does the insider hold after this transaction?

After the grant, the reporting person holds 44,772,230 Tiziana Life Sciences common shares indirectly. These shares are reported as held through Panetta Partners Limited, reflecting the updated total following the 15,000-share award on June 12, 2026.

Was the Tiziana Life Sciences (TLSA) insider transaction an open-market purchase?

No, the transaction was not an open-market purchase. It is coded as “A” on the Form 4, described as a grant, award, or other acquisition of 15,000 common shares at $1.11 per share through Panetta Partners Limited.

How were the newly acquired Tiziana Life Sciences (TLSA) shares held by the insider?

The 15,000 newly acquired shares are reported as held indirectly. The Form 4 lists the nature of ownership as “Via Panetta Partners Limited,” meaning the position is held through that entity rather than directly by the individual.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/17/2026 - 06:31 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CERRONE GABRIELE M

(Last) (First) (Middle)

14-15 CONDUIT ST

(Street)

LONDON W1S2XJ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tiziana Life Sciences Ltd [ TLSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	06/12/2026		A		15,000	A	$1.11	44,772,230	I	Via Panetta Partners Limited

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gabriele M. Cerrone	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)